NRIX Nurix Therapeutics15.16+0.32 (+2.2%)
NRIX Nurix Therapeutics15.49-10.33 (-40.0%)
NRIX Nurix Therapeutics25.69-0.01 (0.0%)
After Hours Decliner
NRIX Nurix Therapeutics15.64+1.00+6.8%
After Hours:15.04-0.60 (-3.9%)
Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
Globe NewswireMon, 8-Jun 1:00 AM
After Hours:15.13-0.51 (-3.3%)
NRIX Nurix Therapeutics15.76+1.12 (+7.7%)